Disclaimer: The information on this page is intended for Vaccine Recipients only.
This medicinal product does not have a Malaysia marketing authorisation but has been granted conditional registration approval by the National Pharmaceutical Regulatory Agency (NPRA), for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals 18 years of age and older. As with any new medicine in Malaysia, this product will be closely monitored to allow quick identification of new safety information. Vaccine Recipients are asked to report any suspected adverse reactions.
Please refer to your Healthcare Provider for further information.